(Q37709577)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Preclinical behavioral models for predicting antipsychotic activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Paul C Moser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Roger D Porsolt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

27 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

Advances in Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

381-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Stress, depression, and anhedonia: caveats concerning animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Function of the CS in shuttle-box avoidance learning by rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Differentiation of haloperidol and clozapine using a complex operant schedule in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Behavioral effects of some psychopharmacological agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Dopamine receptors and average clinical doses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Pre-attentive processing and schizophrenia: animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Challenges in the search for drugs to treat central nervous system disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

1 reference

7 January 2021

The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Visual object processing in schizophrenia: evidence for an associative agnosic deficit.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Recent advances in treating cognitive impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Modern antipsychotic drugs: a critical overview

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Developing translational animal models for symptoms of schizophrenia or bipolar mania

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Animal behavior models of the mechanisms underlying antipsychotic atypicality

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Amnesic effects of scopolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Schizophrenia susceptibility genes: emergence of positional candidates and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Haloperidol-induced tardive dyskinesia in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

MK801-induced hyperactivity: duration of effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Continuous avoidance as a base-line for measuring behavioral effects of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The history of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Novel consortium to address shortfall in innovative medicines for psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The role of the central histaminergic system on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Social class, family history and type of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Suppression of neuroleptic-induced persistent abnormal movements in Cebus apella monkeys by enantiomers of 3-PPP

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activiti

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Emerging opportunities for antipsychotic drug discovery in the postgenomic era.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Removing obstacles in neuroscience drug discovery: the future path for animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Schizophrenia: a concise overview of incidence, prevalence, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Acute dystonia as an idiosyncratic response to neuroleptics in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

PCP: from pharmacology to modelling schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Spatial localization does not require the presence of local cues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The pharmacology of latent inhibition as an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of dopamine receptor antagonists on sucrose consumption and preference

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Quetiapine prevents anhedonia induced by acute or chronic stress

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Schizophrenia genetics: advancing on two fronts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

“Behavioural despair” in rats and mice: Strain differences and the effects of imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Neuroleptic-induced acute dyskinesias in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of piracetam on indices of cognitive function in a delayed alternation task in young and aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Animal models of acute drug-induced akathisia - a review.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The catalepsy test: its ups and downs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Animal cognition: defining the issues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

New antipsychotics and schizophrenia: a review on efficacy and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

An adjusting avoidance schedule

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

A pathophysiological paradigm for the therapy of psychiatric disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Dopamine hypothesis of schizophrenia: making sense of it all.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Prior exposure to phencyclidine decreases voluntary sucrose consumption and operant performance for food reward

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

GABA and Schizophrenia: A Review of Basic Science and Clinical Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Better pharmacotherapy for schizophrenia: what does the future hold?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Performance norms for a rhesus monkey neuropsychological testing battery: acquisition and long-term performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

EPS profiles: the atypical antipsychotics are not all the same

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Screening of antipsychotic drugs in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

New findings from genetic association studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Pimozide does not impair sweetness discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

Low dose MK-801 reduces social investigation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2957010-4

7 January 2021

10.1016/S1054-3589(08)57010-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20230767%20AND%20SRC:MED&resulttype=core&format=json

release_zo7cgvk7b5befn3a47br5vtk44

19 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zo7cgvk7b5befn3a47br5vtk44

24 November 2022

mapped directly with Wikidata item

1 reference